Life Science Success – Podcast

Feb 24, 2023

Evoke Pharma and EVERSANA Selected to Present Results of Real-World Healthcare Utilization Analysis for Diabetic Gastroparesis Patients Treated with GIMOTI® Versus Oral Metoclopramide at the Digestiv

Feb 23, 2023

Posted by EVERSANA

EVERSANA CONSULTING Named a Top Ranked Consulting Firm by Vault Across Asia Pacific

Feb 23, 2023

Posted by EVERSANA

Xspray Pharma Partners with EVERSANA® for the U.S. Launch and Commercialization of its Lead Product, Dasynoc (XS004) for the Treatment of Chronic Myeloid Leukemia (CML) and Acute Lymphatic Leukemia (

Feb 23, 2023

Posted by EVERSANA

Sounds of Science Podcast – Episode 13 on Rare Disease Day 2023

Feb 23, 2023

Azzur Group Appoints New Leadership for Los Angeles Consulting Office

Feb 22, 2023

Ferrer acquires worldwide rights to ASN90, an O-GlcNAcase inhibitor from Asceneuron, exclusively to treat Progressive Supranuclear Palsy (PSP)

Feb 22, 2023